坚持临床试验，与AI保持距离（走近科学大咖⑥）

Core Viewpoint - The article highlights the advancements in research on Amyotrophic Lateral Sclerosis (ALS) led by Dr. Don Cleveland, emphasizing the potential for effective treatments through innovative therapies like Antisense Oligonucleotide (ASO) therapy [2][4][6]. Group 1: Research and Development - Dr. Cleveland focuses on identifying disease-causing genes in neurodegenerative diseases, aiming to reduce their activity to find effective treatments [3]. - ASO therapy involves delivering customized DNA drugs to the nervous system to inhibit the activity of pathogenic genes, with initial experiments proving successful against skepticism [3][4]. - Clinical trials for ALS therapies have seen mixed results, with two successful and two failed trials, indicating the need for ongoing research and patience in the development process [6]. Group 2: Perspectives on Science and Technology - Dr. Cleveland expresses a cautious view on the impact of artificial intelligence (AI) in his field, acknowledging its potential but emphasizing the importance of traditional research methods and long-term clinical trials [5][6]. - He advocates for perseverance in scientific research, stating that new truths often face initial rejection before being accepted as facts [6][7]. Group 3: Global Collaboration and Future of Science - Dr. Cleveland emphasizes the international nature of scientific research, highlighting the importance of collaboration and competition in driving scientific progress [7]. - He notes China's significant investment in scientific research and its potential to become a leader in the next generation of scientific development, contrasting it with the declining investment in other countries [7][8].